- Home
- NDRA vs ONCO Comparison
NDRA vs ONCO Comparison
Compare NDRA & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- ONCO
- Stock Information
- Founded
- NDRA 2007
- ONCO 2018
- Country
- NDRA United States
- ONCO United States
- Employees
- NDRA N/A
- ONCO N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- NDRA Health Care
- ONCO Health Care
- Exchange
- NDRA Nasdaq
- ONCO Nasdaq
- Market Cap
- NDRA 1.7M
- ONCO 1.8M
- IPO Year
- NDRA 2017
- ONCO 2022
- Fundamental
- Price
- NDRA $3.23
- ONCO $0.08
- Analyst Decision
- NDRA Strong Buy
- ONCO
- Analyst Count
- NDRA 1
- ONCO 0
- Target Price
- NDRA $50.00
- ONCO N/A
- AVG Volume (30 Days)
- NDRA 312.7K
- ONCO 45.0M
- Earning Date
- NDRA 05-15-2025
- ONCO 05-27-2025
- Dividend Yield
- NDRA N/A
- ONCO N/A
- EPS Growth
- NDRA N/A
- ONCO N/A
- EPS
- NDRA N/A
- ONCO N/A
- Revenue
- NDRA N/A
- ONCO $1,870,605.00
- Revenue This Year
- NDRA N/A
- ONCO N/A
- Revenue Next Year
- NDRA N/A
- ONCO N/A
- P/E Ratio
- NDRA N/A
- ONCO N/A
- Revenue Growth
- NDRA N/A
- ONCO N/A
- 52 Week Low
- NDRA $2.97
- ONCO $0.05
- 52 Week High
- NDRA $602.00
- ONCO $21.40
- Technical
- Relative Strength Index (RSI)
- NDRA 40.85
- ONCO 49.99
- Support Level
- NDRA $2.90
- ONCO $0.07
- Resistance Level
- NDRA $6.89
- ONCO $0.18
- Average True Range (ATR)
- NDRA 0.98
- ONCO 0.02
- MACD
- NDRA -0.31
- ONCO 0.01
- Stochastic Oscillator
- NDRA 7.17
- ONCO 21.48
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.